LM-168

· LaNova Medicines Limited

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LM-168, covering 2025-09-12 to 2025-09-12. Get the full timeline:

Most recent: Clinical Trial Update: A Study of LM-168 as a Single Agent or in Combination With Toripalimab in Subjects With Advanced Solid Tumours [Phase 1, Phase 2]

See pricing